Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Veterinary Vaccines market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Veterinary Vaccines market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
The Veterinary Vaccines market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Veterinary Vaccines products across developed and developing countries of the world.
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Veterinary Vaccines products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Veterinary Vaccines market.
To learn more about this report
Increasing research and development spending on Veterinary Vaccines development has been the leading industry trend of Veterinary Vaccines market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
To learn more about this report
| Report Attributes | Details |
| The market size value in 2021 | USD XX.XX Million |
| CAGR (2021 - 2028) | XX.XX % |
| The Revenue forecast in 2028 | USD XX.XX Million |
| Base year for estimation | 2021 |
| Historical data | 2018-2019 |
| Forecast period | 2022-2028 |
| Quantitative units |
|
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook | Inactivated Vaccines, Live Attenuated Vaccines, Conjugate Vaccines, Toxoid Vaccines, Recombinant Vaccines, DNA Vaccines, Others |
| By Application Outlook | Veterinary Clinic, Veterinary Hospital, Veterinary Research Institute, Retail Pharmacy, Others |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope | U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled | Elanco, Merck, Merial, Zoetis, Advaxis, AmpliPhi Biosciences, Aratana Therapeutics, ARKO Labs, Bayer, CanFel Therapeutics, Ceva Animal Health, Colorado Serum, Epitopix, Genus, Hygieia Biological Laboratories, ImmuCell, Nexvet, Nuovo Biologics, UBI, Valneva, Vetoquinol, Virbac |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Information Procurement
1.2.1 Purchased Database
1.2.2 Eternity’s Internal Database
1.2.3 Secondary sources & third-party perspectives
1.2.4 Primary Research
1.3 Information analysis
1.4 Market formulation & data visualization
1.5 Data validation & publishing
2 Executive Summary
3 Veterinary Vaccines Market Variables, Trends & Scope
3.1 Market Dynamics
3.1.1 Market Driver Analysis
3.1.2 Market Restraints
3.1.3 Market Challenge Analysis
3.1.4 Market Opportunities
3.1.5 Micro & Macro Indicator
3.2 Impact of COVID-19 Pandemic on Global Veterinary Vaccines Market
3.2.1 Overview of Changing Landscape
3.2.2 Pre-covid & Post-Covid Market Analysis
3.3 Market Attractiveness Analysis
3.4 Regulatory Scenario
3.5 Industry Trend Analysis- Historic and Future Trend Assessment
3.6 Merger & Acquisition
3.7 New System Launch/Approvals
3.8 Market Analysis Tools
3.8.1 Porter’s Five Forces
3.8.2 PEST Analysis
3.8.3 Value Chain Analysis
3.9 Key Company Ranking Analysis, 2020
4 Global Veterinary Vaccines Market Analysis and Forecast, By Type
4.1 Overview & Definition
4.2 Key Trends
4.3 Global Veterinary Vaccines Market Value (US$ Mn) Forecast, by Type (2019 – 2028)
4.2.1 Inactivated Vaccines
4.2.2 Live Attenuated Vaccines
4.2.3 Conjugate Vaccines
4.2.4 Toxoid Vaccines
4.2.5 Recombinant Vaccines
4.2.6 DNA Vaccines
4.2.7 Others
4.4 Type Comparison Matrix
4.5 Global Veterinary Vaccines Market Attractiveness, By Type
5 Global Veterinary Vaccines Market Analysis and Forecast, By Application
5.1 Overview & Definition
5.2 Key Trends
5.3 Global Veterinary Vaccines Market Value (US$ Mn) Forecast, by Application (2019 – 2028)
5.3.1 Veterinary Clinic
5.3.2 Veterinary Hospital
5.3.3 Veterinary Research Institute
5.3.4 Retail Pharmacy
5.3.5 Others
5.4 Application Comparison Matrix
5.5 Global Veterinary Vaccines Market Attractiveness, by Application
6 Global Veterinary Vaccines Market Analysis and Forecast, By Region
6.1 Overview & Definition
6.2 Key Trends
6.3 Global Veterinary Vaccines Market Value (US$ Mn) Forecast, by Region (2019 – 2028)
6.4 North America
6.5 Europe
6.6 Asia Pacific
6.7 Latin America
6.8 Middle East & Africa
7 Global Veterinary Vaccines Market Attractiveness, by Region
8 North America Veterinary Vaccines Market Analysis and Forecast
8.1 Key Findings
8.2 North America Veterinary Vaccines Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
8.2.1 Inactivated Vaccines
8.2.2 Live Attenuated Vaccines
8.2.3 Conjugate Vaccines
8.2.4 Toxoid Vaccines
8.2.5 Recombinant Vaccines
8.2.6 DNA Vaccines
8.2.7 Others
8.3 North America Veterinary Vaccines Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
8.3.1 Veterinary Clinic
8.3.2 Veterinary Hospital
8.3.3 Veterinary Research Institute
8.3.4 Retail Pharmacy
8.3.5 Others
8.4 North America Veterinary Vaccines Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
8.4.1 U.S.
8.4.2 Canada
8.4.3 Rest of North America
8.5 North America Veterinary Vaccines Market Attractiveness Analysis
8.5.1 By Type
8.5.2 By Application
8.5.3 By Country
9 Europe Veterinary Vaccines Market Analysis and Forecast
9.1 Key Findings
9.2 Europe Veterinary Vaccines Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
9.2.1 Inactivated Vaccines
9.2.2 Live Attenuated Vaccines
9.2.3 Conjugate Vaccines
9.2.4 Toxoid Vaccines
9.2.5 Recombinant Vaccines
9.2.6 DNA Vaccines
9.2.7 Others
9.3 Europe Veterinary Vaccines Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
9.3.1 Veterinary Clinic
9.3.2 Veterinary Hospital
9.3.3 Veterinary Research Institute
9.3.4 Retail Pharmacy
9.3.5 Others
9.4 Europe Veterinary Vaccines Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
9.4.1 U.K.
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Rest of Europe
9.5 Europe Veterinary Vaccines Market Attractiveness Analysis
9.5.1 By Type
9.5.2 By Application
9.5.3 By Country
10 Asia Pacific Veterinary Vaccines Market Analysis and Forecast
10.1 Key Findings
10.2 Asia Pacific Veterinary Vaccines Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
10.2.1 Inactivated Vaccines
10.2.2 Live Attenuated Vaccines
10.2.3 Conjugate Vaccines
10.2.4 Toxoid Vaccines
10.2.5 Recombinant Vaccines
10.2.6 DNA Vaccines
10.2.7 Others
10.3 Asia Pacific Veterinary Vaccines Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
10.3.1 Veterinary Clinic
10.3.2 Veterinary Hospital
10.3.3 Veterinary Research Institute
10.3.4 Retail Pharmacy
10.3.5 Others
10.4 Asia Pacific Veterinary Vaccines Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
10.4.1 China
10.4.2 India
10.4.3 Japan
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Asia Pacific Veterinary Vaccines Market Attractiveness Analysis
10.5.1 By Type
10.5.2 By Application
10.5.3 By Country
11 Latin America Veterinary Vaccines Market Analysis and Forecast
11.1 Key Findings
11.2 Latin America Veterinary Vaccines Market Analysis (US$ Mn) and Forecast, By Type (2019-2028)
11.2.1 Inactivated Vaccines
11.2.2 Live Attenuated Vaccines
11.2.3 Conjugate Vaccines
11.2.4 Toxoid Vaccines
11.2.5 Recombinant Vaccines
11.2.6 DNA Vaccines
11.2.7 Others
11.3 Latin America Veterinary Vaccines Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
11.3.1 Veterinary Clinic
11.3.2 Veterinary Hospital
11.3.3 Veterinary Research Institute
11.3.4 Retail Pharmacy
11.3.5 Others
11.4 Latin America Veterinary Vaccines Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
11.4.1 Brazil
11.4.2 Rest of Latin America China
11.5 Latin America Veterinary Vaccines Market Attractiveness Analysis
11.5.1 By Type
11.5.2 By Application
11.5.3 By Country
12 Middle East & Africa (MEA) Veterinary Vaccines Market Analysis and Forecast
12.1 Key Findings
12.2 Middle East & Africa (MEA) Veterinary Vaccines Market Analysis (US$ Mn) and Forecast, By Product Type (2019-2028)
12.2.1 Inactivated Vaccines
12.2.2 Live Attenuated Vaccines
12.2.3 Conjugate Vaccines
12.2.4 Toxoid Vaccines
12.2.5 Recombinant Vaccines
12.2.6 DNA Vaccines
12.2.7 Others
12.3 Middle East & Africa (MEA) Veterinary Vaccines Market Analysis (US$ Mn) and Forecast, By Application (2019-2028)
12.3.1 Veterinary Clinic
12.3.2 Veterinary Hospital
12.3.3 Veterinary Research Institute
12.3.4 Retail Pharmacy
12.3.5 Others
12.4 Middle East & Africa (MEA) Veterinary Vaccines Market Analysis (US$ Mn) and Forecast, By Country (2019-2028)
12.4.1 GCC Countries
12.4.2 South Africa
12.4.3 Rest of MEA
12.5 Middle East & Africa (MEA) Veterinary Vaccines Market Attractiveness Analysis
12.5.1 By Type
12.5.2 By Application
12.5.3 By Country
13 Competitive Landscape
13.1 Market Players – Competition Matrix
13.2 Market Share Analysis by Key Players, 2020 (%)
13.3 Company Profiles
13.3.1 Elanco
13.3.1.1 Company Overview
13.3.1.2 Company Snapshot
13.3.1.3 Financial Overview
13.3.1.4 Product Portfolio
13.3.1.5 Key Developments/Strategies
13.3.2 Merck
13.3.3 Merial
13.3.4 Zoetis
13.3.5 Advaxis
13.3.6 AmpliPhi Biosciences
13.3.7 Aratana Therapeutics
13.3.8 ARKO Labs
13.3.9 Bayer
13.3.10 CanFel Therapeutics
13.3.11 Ceva Animal Health
13.3.12 Colorado Serum
13.3.13 Epitopix
13.3.14 Genus
13.3.15 Hygieia Biological Laboratories
13.3.16 ImmuCell
13.3.17 Nexvet
13.3.18 Nuovo Biologics
13.3.19 UBI
13.3.20 Valneva
13.3.21 Vetoquinol
13.3.22 Virbac
14 Key Takeaways
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
A faster and efficient way to cater to the needs with continuous iteration
Focus on Data Accuracy & Reliability
75+ Clients in Fortune 500
All your transactions are secured end-to-end, ensuring a satisfactory purchase
Ensure the best and affordable pricing
